Suppr超能文献

组织型纤溶酶原激活剂与纤溶酶原激活剂抑制剂1在内皮细胞表面的相互作用。

Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.

作者信息

Sakata Y, Okada M, Noro A, Matsuda M

机构信息

Division of Thrombosis and Hemostasis, Jichi Medical School, Tochigi-Ken, Japan.

出版信息

J Biol Chem. 1988 Feb 5;263(4):1960-9.

PMID:3123483
Abstract

The site of the reaction between plasminogen activators and plasminogen activator inhibitor 1 (PAI-1) was investigated in cultures of human umbilical vein endothelial cells. In conditioned medium from endothelial cells, two forms of a plasminogen activator-specific inhibitor can be demonstrated: an active form that readily binds to and inhibits plasminogen activators and an immunologically related quiescent form which has no anti-activator activity but which can be activated by denaturation. In conditioned medium, only a few percent of PAI-1 is the active form. However, the addition of increasing concentrations of tissue-type plasminogen activator (t-PA) or urokinase to confluent endothelial cells produced a saturable (3.0 pmol/5 x 10(5) cells), dose-dependent increase of the activator-PAI-1 complex in the conditioned medium even in the presence of actinomycin D or cycloheximide. This resulted also in a dose-dependent decrease of the residual PAI activity measured by reverse fibrin autography both in the conditioned medium and cell extracts. Short-time exposure of endothelial cells to a large amount of t-PA caused almost complete depletion of all cell-associated PAI activity. Although there was no detectable PAI activity even after activation of PAI by denaturants or antigen in the culture medium at 4 degrees C without the addition of t-PA, the addition of t-PA at 4 degrees C not only resulted in the formation of 70% of the amount of the t-PA.PAI complex in conditioned medium at 37 degrees C, but also induced PAI-1 antigen in a time and dose-dependent manner in the conditioned medium. Moreover, 125I-labeled t-PA immobilized on Sepharose added directly to endothelial cells formed a complex with PAI-1 in a dose-dependent manner. On the other hand, no detectable complex was formed with PAI-1 when Sepharose-immobilized 125I-labeled t-PA was added to endothelial cells under conditions in which the added t-PA could not contact the cells directly but other proteins could pass freely by the use of a Transwell. All these results suggest that a "storage pool" on the surface of endothelial cells or the extracellular matrix produced by endothelial cells contains almost all the active PAI-1, and reaction between PA and PAI-1 mainly occurs on the endothelial cell membranes, resulting in a decrease of the conversion of active PAI-1 to the quiescent form.

摘要

在人脐静脉内皮细胞培养物中研究了纤溶酶原激活剂与纤溶酶原激活剂抑制剂1(PAI-1)之间的反应位点。在内皮细胞的条件培养基中,可以证明存在两种形式的纤溶酶原激活剂特异性抑制剂:一种活性形式,它能迅速结合并抑制纤溶酶原激活剂;另一种是免疫相关的静止形式,它没有抗激活剂活性,但可通过变性激活。在条件培养基中,只有百分之几的PAI-1是活性形式。然而,向汇合的内皮细胞中添加浓度不断增加的组织型纤溶酶原激活剂(t-PA)或尿激酶,即使在放线菌素D或环己酰亚胺存在的情况下,条件培养基中激活剂-PAI-1复合物也会出现饱和性(3.0 pmol/5×10⁵个细胞)、剂量依赖性增加。这也导致在条件培养基和细胞提取物中通过反向纤维蛋白自显影测量的残余PAI活性呈剂量依赖性降低。内皮细胞短时间暴露于大量t-PA会导致所有细胞相关PAI活性几乎完全耗尽。尽管在不添加t-PA的情况下,即使在4℃下用变性剂或抗原激活培养基中的PAI后也检测不到PAI活性,但在4℃下添加t-PA不仅会导致在37℃条件培养基中形成70%的t-PA·PAI复合物量,还会在条件培养基中以时间和剂量依赖性方式诱导PAI-1抗原。此外,直接添加到内皮细胞上的固定在琼脂糖上的¹²⁵I标记t-PA以剂量依赖性方式与PAI-1形成复合物。另一方面,当在添加的t-PA不能直接接触细胞但其他蛋白质可以通过Transwell自由通过的条件下,将固定在琼脂糖上的¹²⁵I标记t-PA添加到内皮细胞时,未检测到与PAI-1形成复合物。所有这些结果表明,内皮细胞表面或内皮细胞产生的细胞外基质上的“储存池”几乎包含所有活性PAI-1,PA与PAI-1之间的反应主要发生在内皮细胞膜上,导致活性PAI-1向静止形式的转化减少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验